Purpose of the Procedure
- Early detection of Down Syndrome (Trisomy 21).
- Risk assessment for Edwards Syndrome (Trisomy 18) and Patau Syndrome (Trisomy 13).
- Providing a safe alternative to invasive tests like amniocentesis.
Ensure your baby's chromosomal health with the NIPT Basic Panel. This non-invasive screening detects Trisomies 21, 18, and 13 using maternal blood, providing high accuracy and peace of mind during pregnancy.
Scientific name: Non-Invasive Prenatal Testing (NIPT) - Basic Panel
A safe laboratory test analyzing fetal cell-free DNA in maternal blood to detect common chromosomal aneuploidies. It offers high accuracy and can be performed as early as the 10th week of pregnancy.